Status:
COMPLETED
Controlled Study of ONO-5920 in Patients With Involutional Osteoporosis in Japan
Lead Sponsor:
Ono Pharmaceutical Co. Ltd
Conditions:
Involutional Osteoporosis
Eligibility:
FEMALE
45+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to evaluate the efficacy and safety of ONO-5920 in patients with involutional osteoporosis.
Eligibility Criteria
Inclusion
- A diagnosis in accordance with Criteria for the Diagnosis of Primary Osteoporosis.
- Other inclusion criteria as specified in the study protocol.
Exclusion
- Patients having secondary osteoporosis or another condition that presents low bone mass.
- Patients having findings that affect measurement of lumbar spinal bone mineral density by DXA
- Patients that have been administered bisphosphonate derivatives.
- Other exclusion criteria as specified in the study protocol.
Key Trial Info
Start Date :
May 1 2003
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT00212719
Start Date
May 1 2003
Last Update
October 11 2012
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.